Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 2 (2005), Issue 2 (February)

1. Endemic Burkitt's lymphoma: a polymicrobial disease?
   Nat Rev Microbiol, 3(2): 182-7. [Abstract] [Full-text]
2. Sampling of supraorbital brain tissue after death: improving on the clinical diagnosis of cerebral malaria.
   J Infect Dis, 191(5): 805-8. [Abstract] [Full-text]
3. Familial aggregation of cerebral malaria and severe malarial anemia.
   J Infect Dis, 191(5): 799-804. [Abstract] [Full-text]
4. Malarial parasites decrease reproductive success: an experimental study in a passerine bird.
   Oecologia, 142(4): 541-5. [Abstract] [Full-text]
5. Plasmodium falciparum: IgG subclass antibody response to merozoite surface protein-1 among Amazonian gold miners, in relation to infection status and disease expression.
   Exp Parasitol, 109(2): 124-34. [Abstract] [Full-text]
6. Polymorphisms of transporter associated with antigen processing type 1 (TAP1), proteasome subunit beta type 9 (PSMB9) and their common promoter in African children with different manifestations of malaria.
   Int J Immunogenet, 32(1): 7-11. [Abstract] [Full-text]
7. Host population persistence in the face of introduced vector-borne diseases: Hawaii amakihi and avian malaria.
   Proc Natl Acad Sci U S A, 102(5): 1531-6. [Abstract] [Full-text]
8. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.
   J Clin Microbiol, 43(2): 978-81. [Abstract] [Full-text]
9. Placental malaria and pre-eclampsia through the looking glass backwards?
   J Reprod Immunol, 65(1): 1-15. [Abstract] [Full-text]
10. Malaria: immune evasion by parasites.
    Int J Biochem Cell Biol, 37(4): 700-6. [Abstract] [Full-text]
11. Charming the mosquito: do malaria symptoms increase the attractiveness of the host for the vector?
    Med Hypotheses, 64(4): 788-91. [Abstract] [Full-text]
12. Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection.
    Vaccine, 23(13): 1579-87. [Abstract] [Full-text]
13. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.
    Clin Diagn Lab Immunol, 12(2): 242-8. [Abstract] [Full-text]
14. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
    Biochemistry, 44(6): 1768-79. [Abstract] [Full-text]
15. Artemisinins.
    Postgrad Med J, 81(952): 71-8. [Abstract] [Full-text]
16. Management of severe malaria: interventions and controversies.
    Infect Dis Clin North Am, 19(1): 211-40. [Abstract] [Full-text]
17. New strategies for the prevention of malaria in travelers.
    Infect Dis Clin North Am, 19(1): 185-210. [Abstract] [Full-text]
18. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite.
    Proc Natl Acad Sci U S A, 102(6): 1980-5. [Abstract] [Full-text]
19. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial.
    BMJ, 330(7487): 334. [Abstract] [Full-text]
20. Clinical pattern of severe Plasmodium falciparum malaria in Sudan in an area characterized by seasonal and unstable malaria transmission.
    Trans R Soc Trop Med Hyg, 99(4): 243-51. [Abstract] [Full-text]
21. Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum.
    J Biol Chem, 280(7): 5242-8. [Abstract] [Full-text]
22. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Int J Parasitol, 35(2): 185-92. [Abstract] [Full-text]
23. The effects of mosquito transmission and population bottlenecking on virulence, multiplication rate and rosetting in rodent malaria.
    Int J Parasitol, 35(2): 145-53. [Abstract] [Full-text]
24. Clinical and parasitological characteristics of puerperal malaria.
    J Infect Dis, 191(6): 1005-9. [Abstract] [Full-text]
25. Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines.
    Blood, 105(5): 1956-63. [Abstract] [Full-text]
26. Risk factors for fetal anaemia in a malarious area of Malawi.
    Ann Trop Paediatr, 24(4): 311-21. [Abstract] [Full-text]
27. The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria.
    Vox Sang, 88(2): 98-106. [Abstract] [Full-text]
28. Getting down to malarial nuts and bolts: the interaction between Plasmodium vivax merozoites and their host erythrocytes.
    Mol Microbiol, 55(5): 1297-9. [Abstract] [Full-text]
29. A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria.
    J Trop Pediatr, 51(1): 17-24. [Abstract] [Full-text]
30. A surface phospholipase is involved in the migration of plasmodium sporozoites through cells.
    J Biol Chem, 280(8): 6752-60. [Abstract] [Full-text]
31. Anthropometry of fetal growth in rural Malawi in relation to maternal malaria and HIV status.
    Arch Dis Child Fetal Neonatal Ed, 90(2): F161-5. [Abstract] [Full-text]
32. Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection.
    Ann Pharmacother, 39(3): 551-4. [Abstract] [Full-text]
33. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
    Bioorg Med Chem, 13(6): 1945-67. [Abstract] [Full-text]
34. Plasmodium falciparum Malaria: reduction of endothelial cell apoptosis in vitro.
    Infect Immun, 73(3): 1764-70. [Abstract] [Full-text]
35. Review Article: blood-brain barrier in falciparum malaria.
    Trop Med Int Health, 10(3): 285-92. [Abstract] [Full-text]
36. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
    Trop Med Int Health, 10(3): 279-84. [Abstract] [Full-text]
37. Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control.
    Trop Med Int Health, 10(3): 251-62. [Abstract] [Full-text]
38. C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria.
    Int Immunol, 17(3): 245-55. [Abstract] [Full-text]
39. An active transposable element, Herves, from the African malaria mosquito Anopheles gambiae.
    Genetics, 169(2): 697-708. [Abstract] [Full-text]
40. Mechanisms of resistance of malaria parasites to antifolates.
    Pharmacol Rev, 57(1): 117-45. [Abstract] [Full-text]

© 2004-2008 Malaria Research Today. All Rights Reserved.